Posted by Michael Wonder on 12 Dec 2024
Toripalimab in combination with chemotherapy for the first-line treatment of patients with advanced oesophageal squamous cell cancer
11 December 2024 - NICE is unable to make a recommendation on the use in the NHS of toripalimab (Loqtorzi) in combination with chemotherapy for the treatment of adults with untreated advanced oesophageal squamous cell cancer.
This is because Junshi Bioscience has requested a delay to the evidence submission.
